Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Rxo (RXO) Gross Profit (2021 - 2025)

Rxo's Gross Profit history spans 5 years, with the latest figure at $266.0 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 14.19% year-over-year to $266.0 million; the TTM value through Dec 2025 reached $1.1 billion, up 14.82%, while the annual FY2025 figure was $1.1 billion, 14.82% up from the prior year.
  • Gross Profit reached $266.0 million in Q4 2025 per RXO's latest filing, down from $284.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $322.0 million in Q2 2022 to a low of $214.0 million in Q1 2024.
  • Average Gross Profit over 5 years is $264.7 million, with a median of $271.0 million recorded in 2021.
  • Peak YoY movement for Gross Profit: decreased 25.47% in 2023, then soared 31.91% in 2024.
  • A 5-year view of Gross Profit shows it stood at $276.0 million in 2021, then increased by 0.72% to $278.0 million in 2022, then decreased by 15.47% to $235.0 million in 2023, then surged by 31.91% to $310.0 million in 2024, then dropped by 14.19% to $266.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Gross Profit are $266.0 million (Q4 2025), $284.0 million (Q3 2025), and $301.0 million (Q2 2025).